Law ❯ Antitrust Law ❯ Regulatory Compliance ❯ Merger Regulations

U.S. Antitrust Concerns

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Metsera said a call from the FTC about antitrust risks in a rival’s bid drove its switch.